Medical Marijuana Laws Affect Medicare Part D Spending

This article originally appeared here.
Share this content:
Medical Marijuana Laws Affect Medicare Part D Spending
Medical Marijuana Laws Affect Medicare Part D Spending

FRIDAY, July 8, 2016 (HealthDay News) -- Legalization of medical marijuana and its associated availability have affected prescribing patterns and spending in Medicare Part D, according to a study published online July 6 in Health Affairs.

Ashley C. Bradford, and W. David Bradford, Ph.D., both from the University of Georgia in Atlanta, used data on all prescriptions filled by Medicare Part D enrollees from 2010 to 2013 to examine whether medical marijuana is being used clinically to any significant degree.

The researchers found that once a medical marijuana law was implemented, there was a significant decrease in the use of prescription drugs for which marijuana could serve as a clinical alternative. When states implemented medical marijuana laws, the national overall reductions in Medicare program and enrollee spending were estimated to be $165.2 million per year in 2013.

"The availability of medical marijuana has a significant effect on prescribing patterns and spending in Medicare Part D," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

Rising Fatal Drug Overdoses Linked to Years of Life Lost

Rising Fatal Drug Overdoses Linked to Years of ...

Growth in fatal overdoses linked to increased mortality, years of life lost for non-Hispanic whites

Atherosclerotic CVD Mortality Higher in South Asians in the U.S.

Atherosclerotic CVD Mortality Higher in South Asians in ...

Most of the increased risk can be attributed to increased prevalence of known risk factors

Global Variation in Personal Health Care Access and Quality

Global Variation in Personal Health Care Access and ...

Highest performance in Iceland, lowest in Central African Republic, with variation in rate of progress